Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease

Obstructive sleep apnea (OSA) is characterized by intermittent hypoxia during sleep. We tested the hypothesis that nocturnal myocardial ischemia is detectable by ST segment depression and elevation of high sensitive troponin T (hsTrop T) and B-type natriuretic peptide (NT-proBNP) in patients with OS...

Full description

Saved in:
Bibliographic Details
Main Authors: Misa Valo, Annette Wons, Albert Moeller, Claudius Teupe
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Pulmonary Medicine
Online Access:http://dx.doi.org/10.1155/2015/621450
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549943339909120
author Misa Valo
Annette Wons
Albert Moeller
Claudius Teupe
author_facet Misa Valo
Annette Wons
Albert Moeller
Claudius Teupe
author_sort Misa Valo
collection DOAJ
description Obstructive sleep apnea (OSA) is characterized by intermittent hypoxia during sleep. We tested the hypothesis that nocturnal myocardial ischemia is detectable by ST segment depression and elevation of high sensitive troponin T (hsTrop T) and B-type natriuretic peptide (NT-proBNP) in patients with OSA and coexisting coronary artery disease (CAD). Twenty-one patients with OSA and CAD and 20 patients with OSA alone underwent in-hospital polysomnography. Blood samples for hsTrop T and NT-proBNP measurements were drawn before and after sleep. ST segment depression was measured at the time of maximum oxygen desaturation during sleep. The apnea-hypopnea-index (AHI), oxygen saturation nadir, and time in bed with oxygen saturation of ≤80% were similar in both groups. Levels of hsTrop T and NT-proBNP did not differ significantly before and after sleep but NT-proBNP levels were significantly higher in patients suffering from OSA and CAD compared to patients with OSA alone. No significant ST depression was found at the time of oxygen saturation nadir in either group. Despite the fact that patients with untreated OSA and coexisting CAD experienced severe nocturnal hypoxemia, we were unable to detect myocardial ischemia or myocyte necrosis based on significant ST segment depression or elevation of hsTrop T and NT-proBNP, respectively.
format Article
id doaj-art-789572f3a20d470db816519c2e79a068
institution Kabale University
issn 2090-1836
2090-1844
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Pulmonary Medicine
spelling doaj-art-789572f3a20d470db816519c2e79a0682025-02-03T06:08:11ZengWileyPulmonary Medicine2090-18362090-18442015-01-01201510.1155/2015/621450621450Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery DiseaseMisa Valo0Annette Wons1Albert Moeller2Claudius Teupe3Center of Sleep Medicine, Department of Medicine, Krankenhaus Sachsenhausen, 60594 Frankfurt, GermanyCenter of Sleep Medicine, Department of Medicine, Krankenhaus Sachsenhausen, 60594 Frankfurt, GermanyCenter of Sleep Medicine, Department of Medicine, Krankenhaus Sachsenhausen, 60594 Frankfurt, GermanyCenter of Sleep Medicine, Department of Medicine, Krankenhaus Sachsenhausen, 60594 Frankfurt, GermanyObstructive sleep apnea (OSA) is characterized by intermittent hypoxia during sleep. We tested the hypothesis that nocturnal myocardial ischemia is detectable by ST segment depression and elevation of high sensitive troponin T (hsTrop T) and B-type natriuretic peptide (NT-proBNP) in patients with OSA and coexisting coronary artery disease (CAD). Twenty-one patients with OSA and CAD and 20 patients with OSA alone underwent in-hospital polysomnography. Blood samples for hsTrop T and NT-proBNP measurements were drawn before and after sleep. ST segment depression was measured at the time of maximum oxygen desaturation during sleep. The apnea-hypopnea-index (AHI), oxygen saturation nadir, and time in bed with oxygen saturation of ≤80% were similar in both groups. Levels of hsTrop T and NT-proBNP did not differ significantly before and after sleep but NT-proBNP levels were significantly higher in patients suffering from OSA and CAD compared to patients with OSA alone. No significant ST depression was found at the time of oxygen saturation nadir in either group. Despite the fact that patients with untreated OSA and coexisting CAD experienced severe nocturnal hypoxemia, we were unable to detect myocardial ischemia or myocyte necrosis based on significant ST segment depression or elevation of hsTrop T and NT-proBNP, respectively.http://dx.doi.org/10.1155/2015/621450
spellingShingle Misa Valo
Annette Wons
Albert Moeller
Claudius Teupe
Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease
Pulmonary Medicine
title Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease
title_full Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease
title_fullStr Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease
title_full_unstemmed Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease
title_short Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease
title_sort markers of myocardial ischemia in patients with obstructive sleep apnea and coronary artery disease
url http://dx.doi.org/10.1155/2015/621450
work_keys_str_mv AT misavalo markersofmyocardialischemiainpatientswithobstructivesleepapneaandcoronaryarterydisease
AT annettewons markersofmyocardialischemiainpatientswithobstructivesleepapneaandcoronaryarterydisease
AT albertmoeller markersofmyocardialischemiainpatientswithobstructivesleepapneaandcoronaryarterydisease
AT claudiusteupe markersofmyocardialischemiainpatientswithobstructivesleepapneaandcoronaryarterydisease